Loading...

Rising FDA And Payer Pressures Will Limit Market Traction

Published
27 Aug 25
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
-22.6%
7D
5.6%

Author's Valuation

US$197.0% overvalued intrinsic discount

AnalystLowTarget Fair Value